HOME >> BIOLOGY >> NEWS
Targeted Genetics presents advances in synthetic gene delivery technologies

plasmid or the LPD-control gene did not. Further, the combination of LPD-E1A and paclitaxel inhibited tumor growth more efficiently than paclitaxel alone.

"We are making significant progress in our synthetic gene delivery programs," said Dr. Barrie J. Carter, Executive Vice President and Director of Research and Development at Targeted Genetics. "We have shown that LPD enables systemic delivery of therapeutic genes, an important step in the evolution of gene delivery technologies. LPD complexes have several advantages, namely they are compact, stable, efficient and resistant to blood components and thus best suited for intravenous delivery. Systemic delivery of E1A may provide a new approach to treating patients with metastatic disease as well as other cancers that are not amenable to treatment by direct injection. Moreover, the properties of LPD are such that they allow the addition of molecules that can target the complexes to specific tissues. Systemic, targeted delivery has been a long sought after approach to gene therapy and is the foundation of our joint venture with Elan plc (NYSE: ELN), Emerald Gene Systems."

In July 1999, Targeted Genetics and Elan plc established a joint venture, Emerald Gene Systems, to develop advanced gene delivery technologies. The joint venture combines the company's expertise in vector development and manufacturing with Elan's leadership in novel drug delivery technologies. The addition of Elan's targeting technologies to delivery vehicles such as LPD may provide targeted, systemic approaches for the delivery of therapeutic genes.

"These data provide further validation of Targeted Genetics' expertise in the development of gene delivery systems," said Michael Sember, Executive Vice President, Business Development, at Elan. "We believe that systemic gene delivery will catalyze the development of novel treatments for a broad array of significant diseases. Targeted
'"/>

Contact: Page Sargisson
p.sargisson@noonanrusso.com
415-677-4455 x229
Noonan/Russo Communications
8-Dec-1999


Page: 1 2 3 4 5

Related biology news :

1. Targeted therapy knocks out pediatric brain cancer in mice
2. Targeted therapy for lung cancer patients shows promise in extending lives
3. Targeted immunotherapy eradicates cancer in mice
4. Targeted radiation to liver tumors spares tissue, improves quality of life
5. Targeted Genetics presents data on arthritis gene therapy
6. Targeted genetics presents promising data from cystic fibrosis clinical trial
7. Targeted Genetics presents clinical data on E1A cancer gene therapy
8. Targeted Genetics presents advances in systemic gene delivery technology
9. Ribozyme Pharmaceuticals, Inc. Demonstrates Potent Activity Of A Ribozyme Targeted Against The Hepatitis C Virus
10. Fred Hutchinson Cancer Research Center And Targeted Genetics Announces Issuance Of Braod Patent Covering Antigen-Specific T Cell Expansion
11. Marine Snail Toxin Targeted At African Toad Eggs Reveals Novel Impact On The Regulation Of Serotonin

Post Your Comments:
(Date:5/20/2013)... 2013) University of Minnesota Medical School researchers from ... with the University,s Brain Tumor Program, have developed a ... (MPNST) that allow them to discover new genes and ... research was published this week in the journal ... method, researchers in the lab of David Largaespada, Ph.D., ...
(Date:5/20/2013)... effect of physical education (PE) on child weight, but ... the amount of time that elementary schoolchildren spent in ... study represents some of the first evidence of a ... forthcoming in the Journal of Health Economics . ... be viewed at: http://www.sciencedirect.com/science/article/pii/S0167629613000556 , The research ...
(Date:5/20/2013)... rain forest, popularly known as the lungs of the planet, ... dioxide from the air to grow parts that eventually fall ... the region,s plentiful rainfall. , Until recently people believed ... River and ended up deep in the ocean. University of ... amounts of carbon dioxide though left open the question ...
Breaking Biology News(10 mins):U of M researchers develop model for better testing, targeting of MPNST 2Gym class reduces probability of obesity, study finds for first time 2Amazon River exhales virtually all carbon taken up by rain forest 2Amazon River exhales virtually all carbon taken up by rain forest 3
(Date:5/20/2013)... 20, 2013 Oven Industries Inc. announces ... capabilities. The 5R6-900 benchtop controller has many outstanding user-friendly ... be plugged into the wall as a self-contained temperature ... distinctive detail makes the device unique, as well as ... temperature controller can also be used universally, which allows ...
(Date:5/20/2013)... Ga. , May 20, 2013  MiMedx Group, ... manufacturer and marketer of patent protected regenerative biomaterials and ... it has secured a revolving line of credit with ... which is secured by the Company,s accounts receivable and ... through May 1, 2014.  The facility will be used ...
(Date:5/20/2013)... 2013 Today, at the American Psychiatric Association ... James McGough , M.D., M.S., principal ... Institute for Neuroscience and Human Behavior and ... University of California Los Angeles (UCLA), and director of ... and ADHD at UCLA, presented the results of a ...
(Date:5/20/2013)... 2013  (PSHR) Pacific Shore Holdings, Inc. a ... a broad range of product categories lines, today ... firm, BlueWater Advisory Group, to provide strategic counsel ... and to direct the company,s outreach and investor ... Matthew Mills , Pacific Shore Holdings, ...
Breaking Biology Technology:New Laboratory Temperature Controller by Oven Industries 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5Pacific Shore Holdings Retains Investor Relations Firm 2
Cached News: